Campbell Newman Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-6,762
| Closed | -$2.21M | – | 104 |
|
|
2025
Q4 | $2.21M | Hold |
6,762
| – | – | 0.16% | 59 |
|
|
2025
Q3 | $1.91M | Hold |
6,762
| – | – | 0.14% | 71 |
|
|
2025
Q2 | $1.89M | Hold |
6,762
| – | – | 0.15% | 72 |
|
|
2025
Q1 | $2.11M | Hold |
6,762
| – | – | 0.18% | 61 |
|
|
2024
Q4 | $1.76M | Hold |
6,762
| – | – | 0.14% | 71 |
|
|
2024
Q3 | $2.18M | Hold |
6,762
| – | – | 0.16% | 62 |
|
|
2024
Q2 | $2.11M | Sell |
6,762
-238
| -3% | -$69.9K | 0.17% | 56 |
|
|
2024
Q1 | $1.99M | Hold |
7,000
| – | – | 0.16% | 59 |
|
|
2023
Q4 | $2.02M | Hold |
7,000
| – | – | 0.17% | 54 |
|
|
2023
Q3 | $1.88M | Hold |
7,000
| – | – | 0.18% | 55 |
|
|
2023
Q2 | $1.55M | Hold |
7,000
| – | – | 0.14% | 65 |
|
|
2023
Q1 | $1.69M | Hold |
7,000
| – | – | 0.16% | 58 |
|
|
2022
Q4 | $1.84M | Hold |
7,000
| – | – | 0.18% | 56 |
|
|
2022
Q3 | $1.58M | Hold |
7,000
| – | – | 0.18% | 57 |
|
|
2022
Q2 | $1.7M | Hold |
7,000
| – | – | 0.18% | 55 |
|
|
2022
Q1 | $1.69M | Hold |
7,000
| – | – | 0.16% | 63 |
|
|
2021
Q4 | $1.57M | Hold |
7,000
| – | – | 0.14% | 72 |
|
|
2021
Q3 | $1.49M | Hold |
7,000
| – | – | 0.15% | 66 |
|
|
2021
Q2 | $1.71M | Hold |
7,000
| – | – | 0.17% | 63 |
|
|
2021
Q1 | $1.74M | Hold |
7,000
| – | – | 0.18% | 60 |
|
|
2020
Q4 | $1.61M | Hold |
7,000
| – | – | 0.18% | 59 |
|
|
2020
Q3 | $1.78M | Hold |
7,000
| – | – | 0.23% | 51 |
|
|
2020
Q2 | $1.65M | Hold |
7,000
| – | – | 0.23% | 52 |
|
|
2020
Q1 | $1.42M | Hold |
7,000
| – | – | 0.24% | 52 |
|
|
2019
Q4 | $1.69M | Hold |
7,000
| – | – | 0.23% | 51 |
|
|
2019
Q3 | $1.35M | Hold |
7,000
| – | – | 0.19% | 58 |
|
|
2019
Q2 | $1.29M | Sell |
7,000
-53,355
| -88% | -$9.55M | 0.19% | 57 |
|
|
2019
Q1 | $11.5M | Sell |
60,355
-730
| -1% | -$139K | 1.77% | 29 |
|
|
2018
Q4 | $11.9M | Sell |
61,085
-3,009
| -5% | -$587K | 2.07% | 20 |
|
|
2018
Q3 | $13.3M | Sell |
64,094
-1,238
| -2% | -$244K | 1.92% | 25 |
|
|
2018
Q2 | $12.1M | Buy |
65,332
+4,737
| +8% | +$838K | 1.86% | 26 |
|
|
2018
Q1 | $10.3M | Buy |
60,595
+1,023
| +2% | +$188K | 1.72% | 27 |
|
|
2017
Q4 | $10.4M | Sell |
59,572
-2,256
| -4% | -$399K | 1.75% | 27 |
|
|
2017
Q3 | $11.5M | Sell |
61,828
-3,163
| -5% | -$560K | 2.06% | 20 |
|
|
2017
Q2 | $11.2M | Sell |
64,991
-673
| -1% | -$109K | 2.01% | 24 |
|
|
2017
Q1 | $10.8M | Sell |
65,664
-507
| -0.8% | -$84.2K | 1.99% | 24 |
|
|
2016
Q4 | $9.68M | Sell |
66,171
-10,020
| -13% | -$1.51M | 1.86% | 26 |
|
|
2016
Q3 | $12.7M | Sell |
76,191
-201
| -0.3% | -$34K | 2.24% | 24 |
|
|
2016
Q2 | $11.6M | Sell |
76,392
-756
| -1% | -$118K | 2.12% | 23 |
|
|
2016
Q1 | $11.6M | Buy |
77,148
+3,569
| +5% | +$530K | 2.41% | 22 |
|
|
2015
Q4 | $11.9M | Buy |
73,579
+644
| +0.9% | +$101K | 2.6% | 17 |
|
|
2015
Q3 | $10.1M | Sell |
72,935
-5,876
| -7% | -$926K | 2.29% | 21 |
|
|
2015
Q2 | $12.1M | Sell |
78,811
-6,245
| -7% | -$1M | 2.4% | 24 |
|
|
2015
Q1 | $13.6M | Sell |
85,056
-1,256
| -1% | -$198K | 2.5% | 21 |
|
|
2014
Q4 | $13.7M | Buy |
+86,312
| New | +$13.4M | 2.54% | 22 |
|
Other funds holding AMGN
VCM
VPM
Campbell Newman Asset Management's AMGN Position: Q1 2026 in Review
Campbell Newman Asset Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 6,762 shares — an estimated $2.21M sold.
Campbell Newman Asset Management first reported a position in AMGN in Q4 2014 and held it in 45 quarters. The position peaked at $13.7M in Q4 2014. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Campbell Newman Asset Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
- Campbell Newman Asset Management sold 6,762 Amgen shares in Q1 2026, an estimated $2.21M.
- Campbell Newman Asset Management first reported a position in Amgen in Q4 2014 and held it in 45 quarters.
- Campbell Newman Asset Management's Amgen position peaked at $13.7M in Q4 2014.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Campbell Newman Asset Management's 13F filing for Q1 2026, filed 16 Apr 2026.